What is blood and what is not? Caring for the Jehovah's Witness patient undergoing cardiac surgery

Anesthesia and Analgesia

Volumn 104, Issue 4, 2007, Pages 753-754

  Sniecinski, Roman ^a   Levy, Jerrold H ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; BLOOD SUBSTITUTE; ERYTHROPOIETIN; HUMAN SERUM ALBUMIN; IMMUNOGLOBULIN;

ANESTHESIST; BLEEDING; BLOOD AUTOTRANSFUSION; BLOOD COMPONENT; BLOOD DONOR; BLOOD SALVAGE; BLOOD TRANSFUSION; BLOOD VOLUME; CARDIOPULMONARY BYPASS; CIRCULATION; COMMUNITY CARE; CRYOPRECIPITATE; EDITORIAL; ELECTRON MICROSCOPE; ERYTHROCYTE; HEART SURGERY; HUMAN; ISOLATION PROCEDURE; JEHOVAH'S WITNESS; LEUKOCYTE; MEDICAL PRACTICE; MOLECULAR PROBE; PATIENT EDUCATION; PHYSICIAN; PLASMA; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ISOLATION; SOLUBILIZATION; SURGICAL TECHNIQUE; THROMBOCYTE;

EID: 34047276283     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000255644.73211.f2     Document Type: Editorial

References (16)

1. Watch Tower Bible and Tract Society. Questions from readers. Watchtower 2000;15:29-31.
2. Watch Tower Bible and Tract Society. Questions from readers. Watchtower 2004;15:22.
3. Watch Tower Bible and Tract Society. Questions from readers. Watchtower 1978;15:30-1.
4. Watch Tower Bible and Tract Society. Questions from readers. Watchtower 1990;1:30-1.
5. Malan TP, Whitmore J, Maddi R. Reoperative cardiac surgery in a Jehovah's Witness: role of continuous cell salvage and in-line reinfusion. J Cardiothorac Anesth 1989;3:211-14.
6. Khine HH, Naidu R, Cowell H, MacEwen GD. A method of blood conservation in Jehovah's Witnesses: incirculation diversion and reinfusion. Anesth Analg 1978;57:279-80.
7. van Kempen RAB, Gasiorek JM, Bloemendaal K, et al. Low-prime perfusion circuit and autologous priming in CABG surgery on a Jehovah's Witness: a case report. Perfusion 2002;17:69-72.
8. Jovanovic S, Hansbro SD, Munsch CM, Cross MH. Redo cardiac surgery in a Jehovah's Witness, the importance of a multidisciplinary approach to blood conservation. Perfusion 2000;15:251-5.
9. Rosengart TK, Helm RE, DeBois WJ, et al. Open heart operations without transfusion using a multimodality blood conservation strategy in 50 Jehovah's Witness patients: implications for a "bloodless" surgical technique. J Am Coll Surg 1997;184:618-29.
10. Rosengart TK, Helm RE, Klemperer J, et al. Combined aprotinin and erythropoietin use for blood conservation: results with Jehovah's Witnesses. Ann Thorac Surg 1994;58:1397-403.
11. Beholz S, Liu J, Thoelke R, et al. Use of desmopressin and erythropoietin in an anaemic Jehovah's Witness patient with severely impaired coagulation capacity undergoing stentless aortic valve replacement. Perfusion 2001;16:485-9.
12. Tanaka KA, Waly AA, Cooper WA, Levy JH. Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant Factor VIIa (Novoseven). Anesthesiology 2003;98:1513-15.
13. Ott DA, Cooley DA. Cardiovascular surgery in Jehovah's Witnesses. Report of 542 operations without blood transfusion. JAMA 1977;238:1256-8.
14. Levy JH. Hemoglobin-based oxygen-carrying solutions: close but still so far.[comment]. Anesthesiology 2000;92:639-41.
15. Levy JH, Despotis GJ, Szlam F, et al. Recombinant human transgenic antithrombin in cardiac surgery: a dose-finding study. Anesthesiology 2002;96:1095-102.
16. Levy JH, Fingerhut A, Brott T, et al. Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: review of safety profile. Transfusion 2006;46:919-33.